NIH-funded research R21 grant

Investigating how age, sex, and hormones affect inflammation in heart disease

Official title: Age, sex, hormonal status, and anti-inflammatory therapy for atherosclerosis

Funded at Saint Louis University · NIH-10999643 · Data updated 2026-11-12

This study is looking at how aging, hormones, and inflammation might affect heart disease, especially in women after menopause, and it aims to find new ways to help prevent or treat heart problems as we get older.

More Atherosclerosis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSaint Louis University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$416,625
NIH project number1R21AG089957-01
Project IDNIH-10999643 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include older adults, particularly postmenopausal women, who are at risk for cardiovascular diseases.

Less likely to help

Patients who are younger and do not have risk factors for cardiovascular disease may not benefit from this research.

What this research studies

This research explores the relationship between age, sex, hormonal changes, and inflammation in the development of atherosclerotic cardiovascular disease (CVD). It focuses on how the loss of ovarian hormones in women after menopause may increase inflammation and contribute to heart disease. By studying both male and female mice, the researchers aim to identify additional mechanisms that drive atherosclerosis beyond cholesterol levels. The ultimate goal is to discover new therapies that can better manage or prevent heart disease in aging populations.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that more effectively reduce the risk of heart disease in older adults.

How similar studies have gone: Previous research has shown that targeting inflammation can be beneficial in managing cardiovascular diseases, suggesting that this approach may yield promising results.

Where this research is happening

  • Saint Louis University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Baldan, Angel — Saint Louis University
  • Study coordinator: Baldan, Angel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.